Hormigo et al. observed that levels of MMP-9 were higher in the sera samples of patients with high-grade glioma after surgery, suggesting that increases in the serum level of this protein may be associated with brain inflammation and breakdown of the blood–brain barrier, rather than be a true measure of tumour burden [45]. The gene discussed is MMP9; the disease is central nervous system cancer.